Improving Profitability A Key Mid-Term Focus For Takeda
Executive Summary
CEO Christophe Weber remains resolutely upbeat on the progress of Takeda's strategic transformation plan, the dividends of which he said are apparent in the leading Japanese pharma firm's fiscal year performance.